Abstract
MicroRNA-455-5p (miR-455-5p) seems to have an anti-inflammatory role in the immune system since its expression is induced by IL-10 cytokine. Multiple sclerosis (MS) is a chronic demyelinating neurodegenerative disease of the central nervous system that is caused by an autoimmune inflammatory attack against the myelin insulation of neurons. The expression level of miR-455-5p and its role in MS pathogenesis has yet to be elucidated. We found that miR-455-5p expression was highly correlated with disease severity in MS patients. miR-455-5p expression inversely correlates with its inflammatory-predicted targets (MyD88 and REL) in relapse- and remitting-phase patients. Luciferase assays confirm that MyD88 and REL are direct targets of miR-455-5p. This study represents the first report of the miR-455-5p acts as an anti-inflammatory role in MS, at least partially through targeting MyD88 and REL. This study may provide important information for the use of miR-455-5p as a novel strategy to improve the severity of disease and control inflammation and attack in MS patients.
Similar content being viewed by others
References
Cardwell LN, Weaver BK (2014) IL-10 inhibits LPS-induced expression of miR-147 in murine macrophages. Adv Biol Chem 4:261–273
Chitnis T, Weiner HL (2017) CNS inflammation and neurodegeneration. J Clin Investig 127:3577–3587
Cunha F, Mohcada S, Liew F (1992) Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem Biophys Res Commun 182:1155–1159
Du C et al (2009) MicroRNA miR-326 regulates T H-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 10:1252–1259
Ersoy E, Kuş C, Şener U, Coker I, Zorlu Y (2005) The effects of interferon-β on interleukin-10 in multiple sclerosis patients. Eur J Neurol 12:208–211
Guo B (2016) IL-10 modulates Th17 pathogenicity during autoimmune diseases Journal of clinical & cellular immunology 7
Hilliard BA, Mason N, Xu L, Sun J, Lamhamedi-Cherradi SE, Liou HC, Hunter C, Chen YH (2002) Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J Clin Investig 110:843–850
Kouhkan F, Soleimani M, Daliri M, Behmanesh M, Mobarra N (2013) miR-451 up-regulation, induce erythroid differentiation of CD133+ cells independent of cytokine cocktails. Iran J Basic Med Sci 16:756
Kouhkan F, Mobarra N, Soufi-Zomorrod M, Keramati F, Hosseini Rad SMA, Fathi-Roudsari M, Tavakoli R, Hajarizadeh A, Ziaei S, Lahmi R, Hanif H, Soleimani M (2016) MicroRNA-129-1 acts as tumour suppressor and induces cell cycle arrest of GBM cancer cells through targeting IGF2BP3 and MAPK1. J Med Genet 53:24–33
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1444
Lassmann H (2018) Multiple sclerosis pathology. Cold Spring Harbor Perspect Med 8:a028936
Leibowitz SM, Yan J (2016) NF-κB pathways in the pathogenesis of multiple sclerosis and the therapeutic implications. Front Mol Neurosci 9:84
Li Q-J, Chau J, Ebert PJR, Sylvester G, Min H, Liu G, Braich R, Manoharan M, Soutschek J, Skare P, Klein LO, Davis MM, Chen CZ (2007) miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129:147–161
Liu T, Zhang L, Joo D, Sun S-C (2017) NF-κB signaling in inflammation. Signal Transduction Targeted Ther 2:17023
Marziniak M, Meuth S (2014) Current perspectives on interferon Beta-1b for the treatment of multiple sclerosis. Adv Ther 31:915–931
Matute C, Alberdi E, Domercq MA, Pérez-Cerdá F, Pérez-Samartin A, Sánchez-Gómez MAV (2001) The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci 24:224–230
Mc Guire C, Prinz M, Beyaert R, van Loo G (2013) Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology. Trends Mol Med 19:604–613
Miranda-Hernandez S, Gerlach N, Fletcher JM, Biros E, Mack M, Körner H, Baxter AG (2011) Role for MyD88, TLR2 and TLR9 but not TLR1, TLR4 or TLR6 in experimental autoimmune encephalomyelitis. J Immunol 187:791–804
O’Connell RM, Rao DS, Chaudhuri AA, Baltimore D (2010) Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10:111–122. https://doi.org/10.1038/nri2708
Obeidi N, Pourfathollah AA, Soleimani M, Zarif MN, Kouhkan F (2016) The Effect of mir-451 upregulation on erythroid lineage differentiation of murine embryonic stem cells. Cell J (Yakhteh) 18:165
Park S-H, Cho G, Park S-G (2014) NF-κB activation in T helper 17 cell differentiation. Immun Netw 14:14–20
Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V, Volinia S, Alder H, Liu CG, Rassenti L, Calin GA, Hagan JP, Kipps T, Croce CM (2006) Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 66:11590–11593
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302
Ruan Q, Chen YH (2012) Nuclear factor-κB in immunity and inflammation: the Treg and Th17 connection. In: Current Topics in Innate Immunity II Springer, pp 207–221
Tak PP, Firestein GS (2001) NF-κB: a key role in inflammatory diseases. J Clin Investig 107:7–11
Tasharrofi N, Kouhkan F, Soleimani M, Soheili ZS, Saber MM, Dorkoosh FA (2017) Survival improvement in human retinal pigment epithelial cells via fas receptor targeting by miR-374a Journal of cellular biochemistry
de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220
Wu T, Chen G (2016) miRNAs participate in MS pathological processes and its therapeutic response mediators of inflammation 2016
Zhang J, Cheng Y, Cui W, Li M, Li B, Guo L (2014) MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol 266:56–63
Zhang H, Bi J, Yi H, Fan T, Ruan Q, Cai L, Chen YH, Wan X (2017) Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in mice. Immunol Cell Biol 95:593–600
Zomorrod MS, Kouhkan F, Soleimani M, Aliyan A, Tasharrofi N (2018) Overexpression of miR-133 decrease primary endothelial cells proliferation and migration via FGFR1 targeting Experimental cell research
Acknowledgements
The authors are thankful for the valuable contribution of the patients included in the study. They are grateful to Dr. Abdorreza Naser Moghadasi for his excellent assistance and scientific advice in patient sample collection and patient categorization.
Funding
This work was supported by a research grant from the Stem cell Technology Research Center, Tehran, Iran.
Author information
Authors and Affiliations
Corresponding author
Additional information
Shukoofeh Torabi and Mona Tamaddon are Shared first authors.
Rights and permissions
About this article
Cite this article
Torabi, S., Tamaddon, M., Asadolahi, M. et al. miR-455-5p downregulation promotes inflammation pathways in the relapse phase of relapsing-remitting multiple sclerosis disease. Immunogenetics 71, 87–95 (2019). https://doi.org/10.1007/s00251-018-1087-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00251-018-1087-x